Class IIReported 2024-12-25

Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05

Recalled by Provepharm Inc.

Reason for Recall

Discoloration

Recall Number

D-0150-2025

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2024-11-22

Reported

2024-12-25

Distribution

Nationwide within the United States

Code Info

Lot #: F9026F01, F9026F02, Exp. Date 12/2025

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.